Evidence map›Paper›PMID 40079011›Full record

ArticleFrontiers in immunology2025

Hong-Chao Sun, Xiu-Fang Yuan, Wei Zhou, Zhi-Jin Zhou, Fei Su, Yuan Fu, Li-Li Hao, Xin Liu, Xin Zhou, Shi-Yi Ye and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Advances and Translational Challenges inVeterinary sciences · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hong-Chao SunInstitute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, China.
Xiu-Fang YuanInstitute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, China.
Wei ZhouZhejiang Center of Animal Disease Control, Hangzhou, Zhejiang, China.
Zhi-Jin ZhouZhejiang Center of Animal Disease Control, Hangzhou, Zhejiang, China.
Fei SuInstitute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, China.
Yuan FuInstitute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, China.
Li-Li HaoDepartment of Animal Parasitology, College of Animal and Veterinary Sciences, Southwest Minzu University, Chengdu, Sichuan, China.
Xin LiuDepartment of Animal Parasitology, College of Animal and Veterinary Sciences, Southwest Minzu University, Chengdu, Sichuan, China.
Xin ZhouInstitute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, China.
Shi-Yi YeInstitute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, China.
Li-Hua XuInstitute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, China.
Bin YuInstitute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, China.
Jun-Xing LiInstitute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, China.
Tuan-Yuan ShiInstitute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: A recombinant spore named rBS-GRA12 was constructed by fusing the Results: Amylase activity assays confirmed the generation of recombinant Conclusion: Mice immunized with rBS-GRA12 exhibited higher levels of cellular, humoral, and mucosal immune responses than control mice. These results provide a new perspective for the development of

Indexed as

Antigens, ProtozoanBacillus subtilisProtozoan ProteinsProtozoan VaccinesSpores, BacterialToxoplasmaToxoplasmosisToxoplasmosis, AnimalAnimalsAntibodies, ProtozoanCytokinesFemaleMiceMice, Inbred BALB CAntibodies, ProtozoanAntigens, ProtozoanCytokinesProtozoan ProteinsProtozoan VaccinesBacillus subtilisGRA12protective efficacytoxoplasmosisvaccine

Identifiers

PMID40079011
PMCPMC11897052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.